3
Participants
Start Date
October 31, 2022
Primary Completion Date
September 28, 2023
Study Completion Date
September 28, 2023
GWP42003-P
oral solution
Placebo
oral solution
Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS, Genova
IRCCS Fondazione Istituto Neurologico Nazionale D. Mondino Pavia, Pavia
Wake Forest Baptist Health Sciences, Department of Neurology, Winston-Salem
Medical University of South Carolina, Charleston
Healthcare of Atlanta, Atlanta
Children's Hospital of Alabama, Birmingham
UOC Neuropsichiatria Infantile AOUI Verona, Verona
Cincinnati Children's Hospital Medical Center - TS Clinic, Cincinnati
Azienda Ospedaliero Universitaria Ospedale Pediatrico Meyer, Florence
Mayo Clinic, Rochester
Ann & Robert H. Lurie Children's Hospital, Chicago
Dell's Children's Hospital, Austin
University of California Davis Health, Sacramento
Seattle Children's Hospital, Seattle
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY